Viewing Study NCT03372057


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-01-02 @ 12:50 AM
Study NCT ID: NCT03372057
Status: COMPLETED
Last Update Posted: 2025-03-07
First Post: 2017-12-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Duvelisib in Participants With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Sponsor: SecuraBio
Organization: